
© 2024 ARIVA.de
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Abbott bolsters its Heart Failure leadership | ||
Di | Oppenheimer maintains Abbott stock Outperform with $134 target | ||
So | Abbott Laboratories (ABT): One of the Best Dividend Kings to Buy for Safe Dividend Growth | ||
Fr | Piper Sandler maintains Overweight on Abbott Labs with $133 target | ||
Fr | Here's What to Expect From Abbott Laboratories' Next Earnings Report |